Regional Variation in Guttae Distribution in Fuchs Endothelial Corneal Dystrophy
Ophthalmology Science · 2025-09 · 5 (5) · 100817
DOI: 10.1016/j.xops.2025.100817 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmology Science, 2025-09. Verfasst von Yasufumi Tomioka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Purpose
To investigate regional variations in guttae distribution in Fuchs endothelial corneal dystrophy (FECD) and evaluate its relationship with anatomical ultraviolet (UV) protection by the eyelid.
Design
A prospective observational study.
Participants
This study involved 19 eyes of 19 patients with FECD between April 2022 and June 2024 at Kyoto Prefectural University of Medicine.
Methods
Using slit-scanning wide-field contact specular microscopy, we analyzed guttae distribution in 5 corneal regions (central, superior, temporal, nasal, and inferior). Marginal reflex distance (MRD) was measured to assess the eyelid position. Proportion of guttae was quantified using image analysis. Main Outcome Measures: Regional differences in guttae distribution and correlation with MRD measurements.
Results
The superior region demonstrated a significantly lower proportion of guttae (29.4%) compared with central (69.0%), temporal (57.4%), and nasal areas (57.5%) (all P < 0.05). The difference between superior and inferior areas (45.6%) was not significant (P = 0.08). Margin reflex distance measurements showed no significant correlation with superior guttae distribution (P = 0.40).
Conclusions
Our study reveals a distinct regional variation in FECD progression, with relative sparing of the superior cornea suggesting potential UV-protective mechanisms. Although not directly correlated with eyelid position, these findings indicate that environmental factors may influence disease progression. This insight suggests the potential benefit of UV protection as a preventive strategy, particularly in early-stage FECD patients. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Department of Mechanical Systems Engineering, Graduate School of Systems Design, Tokyo Metropolitan University, Tokyo, Japan.
- Institute for Physical Chemistry, Heidelberg University, Heidelberg, Germany.
- Center for Integrative Medicine and Physics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Cornea Center of Excellence, Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts.
- Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Tomioka, Y., Ueno, M., Yamamoto, A., Kitazawa, K., Fukuoka, H., Tanaka, M., Sotozono, C., Jurkunas, U. V., & Kinoshita, S. (2025). Regional Variation in Guttae Distribution in Fuchs Endothelial Corneal Dystrophy. Ophthalmology Science, 5(5), 100817. https://doi.org/10.1016/j.xops.2025.100817
Vancouver
Tomioka Y, Ueno M, Yamamoto A, Kitazawa K, Fukuoka H, Tanaka M, et al. Regional Variation in Guttae Distribution in Fuchs Endothelial Corneal Dystrophy. Ophthalmology Science. 2025;5(5):100817. doi:10.1016/j.xops.2025.100817
BibTeX
@article{Tomioka2025,
author = {Tomioka, Yasufumi and Ueno, Morio and Yamamoto, Akihisa and Kitazawa, Koji and Fukuoka, Hideki and Tanaka, Motomu and Sotozono, Chie and Jurkunas, Ula V and Kinoshita, Shigeru},
title = {Regional Variation in Guttae Distribution in Fuchs Endothelial Corneal Dystrophy},
journal = {Ophthalmology Science},
year = {2025},
volume = {5},
number = {5},
pages = {100817},
doi = {10.1016/j.xops.2025.100817}
}
EUVIMED